1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Impact on follow-up strategies in patients with primary sclerosing cholangitis
(
- Contribution to journal › Article
- 2022
-
Mark
Development of a novel MRCP-score for patients with primary sclerosing cholangitis, and assessment of agreement and prognostic value
(
- Contribution to journal › Published meeting abstract
-
Mark
Development of a prognostic MRCP score (DiStrict) for patients with large-duct primary sclerosing cholangitis
(
- Contribution to journal › Article
- 2021
-
Mark
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
(
- Contribution to journal › Article
- 2020
-
Mark
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
(
- Contribution to journal › Article
- 2019
-
Mark
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
(
- Contribution to journal › Article
- 2017
-
Mark
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
(
- Contribution to journal › Article
-
Mark
Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis
(
- Contribution to journal › Article
- 2016
-
Mark
Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis
(
- Contribution to journal › Article